The Cronos Group group tops the results of the second quarter 2025

Cronos Group Inc. (Nasdaq:CrohnFrom among 12 best marijuana shares to buy according to analysts. CRONOS Group Inc. (NASDAQ: CRON) for the net revenue of $ 33.5 million for the second quarter of 2025, by 21 % on an annual basis. Growth was due to the crowding of flower sales in cannabis in Israel and international markets, the unification of Chronus Corko, and the strongest Canadian summaries sales. The total profit increased from $ 8.2 million in the second quarter from 2024 to $ 14.5 million. The modified Ebitda increased by $ 12.7 million from the previous year to $ 1.7 million. CRONOS recorded a net loss of $ 38.5 million despite the advantages of sales growth and efficiency.

Cronos Group Inc. (NASDAQ: CRON) with the PEACE NATURALS® space as a brand in the leading hemp, which prompted the country’s record sales. CEO Mike Gorstein pointed to the growth of the planned flower capacity and strong global momentum to reduce the supply restrictions in Canada. Flower sales of this quarter brought about $ 2.2 million to Cronos Growco. The company maintains a strong public budget of $ 834 million in cash, not debt, allowing it to support international growth and innovation in brands including Lord Jones® and Spinach®. It is one of The best marijuana stock.

Although we acknowledge the CRAN capabilities as an investment, we believe that some of the artificial intelligence shares provide greater potential in the upward direction and carry less risks on the negative side. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read the following: 10 high -growth shares EV to invest in them and 13 best car shares to buy in 2025.

Detection. no one.